Inventor · disambiguated record
Matthew E. Voss
Also filed as: VOSS MATTHEW · VOSS MATTHEW E · VOSS MATTHEW ERNST
31 granted patents·8 pending applications·220 citations·filing 1992–2025
96Inventor score
Files withMERCK SHARP & DOHME7DU PONT MERCK PHARMA6BRISTOL MYERS SQUIBB PHARMA CO4ALBANY MOLECULAR RES INC3AMR TECHNOLOGY INC3
Top patents by PatentIndex Score
39 records- 0192US7235564B2Vinorelbine derivativesAMR TECHNOLOGY INC·Filed 2004·Granted Jun 26, 2007·26 cites·56 claims
- 0291US6495565B2β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-αBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Dec 17, 2002·50 cites·70 claims
- 0390US7884107B2Substituted piperidines that increase P53 activity and the uses thereofMERCK·Filed 2007·Granted Feb 8, 2011·32 cites·36 claims
- 0485US5710159AIntegrin receptor antagonistsDU PONT MERCK PHARMA·Filed 1996·Granted Jan 20, 1998·39 cites·21 claims
- 0582US6984648B2Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-αBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Jan 10, 2006·15 cites·21 claims
- 0679US7238704B2Vinca derivativesAMR TECHNOLOGY INC·Filed 2004·Granted Jul 3, 2007·10 cites·109 claims
- 0778US7745619B2Vinca derivativesALBANY MOLECULAR RES INC·Filed 2007·Granted Jun 29, 2010·2 cites·4 claims
- 0877US9682978B22,6,7 substituted purines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Jun 20, 2017·2 cites·10 claims
- 0977US7338975B2Lactams as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Mar 4, 2008·8 cites·14 claims
- 1077US2025383605A1Alkylsulfonic acid developer compositions and patterning methods for organometallic oxide photoresistsINPRIA CORP·Filed 2025·Application pending·0 cites
- 1175US8962611B2Substituted imidazopyridines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Feb 24, 2015·1 cites·20 claims
- 1275US8846657B2Substituted imidazopyridines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Sep 30, 2014·1 cites·30 claims
- 1370US9540377B22,6,7,8 substituted purines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Jan 10, 2017·2 cites·15 claims
- 1467US7842802B2Vinorelbine derivativesALBANY MOLECULAR RES INC·Filed 2008·Granted Nov 30, 2010·0 cites·3 claims
- 1567US2025270240A1Organometallic compositions with polyene ligands, radiation sensitive coatings with bridging organic ligands and patterningINPRIA CORP·Filed 2025·Application pending·0 cites
- 1665US8859776B2Substituted piperidines that increase p53 activity and the uses thereofBOGEN STEPHANE L·Filed 2010·Granted Oct 14, 2014·2 cites·44 claims
- 1765US2008051425A1Vinorelbine derivativesAMR TECHNOLOGY INC·Filed 2007·Application pending·0 cites
- 1864US6884806B2Bicyclic lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)BRISTOL MYERS SQUIBB CO·Filed 2002·Granted Apr 26, 2005·2 cites·18 claims
- 1963US2024085785A1Additives for metal oxide photoresists, positive tone development with additives, and double bake double develop processingINPRIA CORP·Filed 2023·Application pending·0 cites
- 2062US8053428B2Vinorelbine derivativesALBANY MOLECULAR RES INC·Filed 2007·Granted Nov 8, 2011·0 cites·43 claims
- 2162US6720329B2Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)BRISTOL MYERS SQUIBB PHARMA·Filed 2002·Granted Apr 13, 2004·1 cites·28 claims
- 2262US5272269ADisubstituted polycyclic systems and preparative methods thereforDU PONT MERCK PHARMA·Filed 1992·Granted Dec 21, 1993·10 cites·20 claims
- 2361US2025109110A1Bicyclic-substituted epithelial sodium channel blocking compoundsPARION SCIENCES INC·Filed 2023·Application pending·0 cites
- 2461US2025115561A1Biphenyl-substituted epithelial sodium channel blocking compoundsPARION SCIENCES INC·Filed 2023·Application pending·0 cites
- 2559US8895543B2Vinca derivativesSCOTT IAN L·Filed 2007·Granted Nov 25, 2014·0 cites·50 claims
- 2654US7777040B2Certain substituted ureas, as modulators of kinase activityCGI PHARMACEUTICALS INC·Filed 2006·Granted Aug 17, 2010·0 cites·30 claims
- 2753US6365587B1Substituted aryl hydroxamic acids as metalloproteinase inhibitorsFiled 1999·Granted Apr 2, 2002·9 cites·20 claims
- 2852US6962938B2Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)BRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Nov 8, 2005·0 cites·19 claims
- 2950US2014336222A1SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE USES THEREOFMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 3048US2003073682A1Novel substituted aryl hydroxamic acids as metalloproteinase inhibitorsFiled 2002·Application pending·0 cites
- 3146US8222421B2Certain substituted ureas, as modulators of kinase activityMITCHELL SCOTT A·Filed 2010·Granted Jul 17, 2012·0 cites·34 claims
- 3246US5308851ABispyridyl-containing heterocycles useful for treating cognitive disordersDU PONT MERCK PHARMA·Filed 1993·Granted May 3, 1994·2 cites·12 claims
- 3344US9637493B2Substituted pyrrolopyrimidines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted May 2, 2017·0 cites·15 claims
- 3444US5414004ANeurotransmitter releasers useful for cognition enhancementDU PONT MERCK PHARMA·Filed 1993·Granted May 9, 1995·2 cites·51 claims
- 3542US9062071B2Substituted piperidines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2012·Granted Jun 23, 2015·0 cites·16 claims
- 3640US8980916B2Factor IXa inhibitorsVOSS MATTHEW·Filed 2012·Granted Mar 17, 2015·0 cites·16 claims
- 3739US6455522B1Cyclic sulfonamide derivatives as metalloproteinase inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Sep 24, 2002·3 cites·36 claims
- 3834US5424430ADisubstituted polycyclic systems and preparative methods thereforDU PONT MERCK PHARMA·Filed 1993·Granted Jun 13, 1995·1 cites·17 claims
- 3930US5532247ANeurotransmitter releasers useful for cognition enhancementDU PONT MERCK PHARMA·Filed 1995·Granted Jul 2, 1996·0 cites·33 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →